CV vs REG · rev $3.5M vs P/E 34, $12.93B cap
CapsoVision, Inc. Common Stock (CV) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
CapsoVision, Inc. Common Stock (CV) is a medical devices company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported CV revenue for 2025-09-30 was $3.5M. Net income was -$7.9M. Revenue was up 6.7% from 2025-06-30 to 2025-09-30. CV currently screens at market cap $359.2M.
REG does not have a complete income-statement cache yet.
CV currently screens at market cap $359.2M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the CV and REG stock pages for the full models.
Not investment advice.